27
Participants
Start Date
October 31, 2005
Primary Completion Date
June 30, 2011
Study Completion Date
June 30, 2011
Zarnestra
ZARNESTRA 100 bid (phase II recommended dose defined in phase I)will be administered continuously from one week prior to start of radiation therapy until the last day of radiation therapy.
standard Radiation therapy
Radiotherapy will be focused on the initial tumour volume with a reasonable margin of safety (2 cm). A total dose of 60 Gray (Gy) will be given to the Clinical Target Volume
Centre Jean Perrin, Clermont-Ferrand
Institut Claudius Regaud, Toulouse
Janssen-Cilag Ltd.
INDUSTRY
Institut Claudius Regaud
OTHER